Enhanced detection rate of Mycoplasma genitalium in urine overtime by transcription-mediated amplification in comparison to real-time PCR.
Antimicrobial resistance
Molecular diagnostic techniques
Mycoplasma genitalium
Nucleic acid amplification test
Sexually transmitted infection
Transcription-mediated amplification
Journal
BMC infectious diseases
ISSN: 1471-2334
Titre abrégé: BMC Infect Dis
Pays: England
ID NLM: 100968551
Informations de publication
Date de publication:
04 Sep 2023
04 Sep 2023
Historique:
received:
31
03
2023
accepted:
31
07
2023
medline:
6
9
2023
pubmed:
5
9
2023
entrez:
4
9
2023
Statut:
epublish
Résumé
Diagnosis of infected individuals with Mycoplasma genitalium (MG) is often performed by real-time PCR or transcription-mediated amplification (TMA). A limitation of the MG-TMA assay is the relatively short time span of 24 h in which the collected urine is required to be transferred into a Urine Specimen Transport Tube, according to the manufacturer's guidelines. If not transferred within 24 h, the manufacturer's claimed sensitivity cannot be guaranteed anymore, and samples may instead be tested with an in-house validated real-time PCR, despite its recognized lower sensitivity. This study aimed to validate an exception to the sample transport and storage conditions of the MG-TMA assay as set by the manufacturer, being the prolongation of the acceptable testing time limit of 24 h. From June to December 2022, first-void urines were collected from clients attending the clinic for sexual health in Amsterdam, the Netherlands. Urine samples that tested positive for MG by TMA assay at the day of collection were concomitantly stored at room (18-24 °C) and refrigerator temperature (4-8 °C) for 15 days. The stored urine samples were tested with both an in-house validated real-time PCR and MG-TMA assay after transfer of the original urine samples to the respective test tubes at 3, 7, 12 and 15 days post collection. In total, 47 MG-positive urine samples were collected, stored and tested for MG by real-time PCR and TMA assays. After storage at room temperature, the MG-detection rate by TMA was significantly higher compared to real-time PCR, at days 0 (p ≤ 0.001), 7 (p ≤ 0.001) and 12 (p < 0.05). After storage at refrigerator temperature, the MG-detection rate determined by TMA assay was significantly enhanced in comparison with real-time PCR at days 3 (p < 0.01), 7 (p ≤ 0.001) and 15 (p < 0.01). This validation study showed that the MG-TMA assay has a superior detection rate in urine compared to real-time PCR, up to 15 days post sample collection and irrespective of storage temperature. Accepting urines older than 24 h to be tested by TMA will improve clinical diagnosis of MG infections.
Sections du résumé
BACKGROUND
BACKGROUND
Diagnosis of infected individuals with Mycoplasma genitalium (MG) is often performed by real-time PCR or transcription-mediated amplification (TMA). A limitation of the MG-TMA assay is the relatively short time span of 24 h in which the collected urine is required to be transferred into a Urine Specimen Transport Tube, according to the manufacturer's guidelines. If not transferred within 24 h, the manufacturer's claimed sensitivity cannot be guaranteed anymore, and samples may instead be tested with an in-house validated real-time PCR, despite its recognized lower sensitivity. This study aimed to validate an exception to the sample transport and storage conditions of the MG-TMA assay as set by the manufacturer, being the prolongation of the acceptable testing time limit of 24 h.
METHODS
METHODS
From June to December 2022, first-void urines were collected from clients attending the clinic for sexual health in Amsterdam, the Netherlands. Urine samples that tested positive for MG by TMA assay at the day of collection were concomitantly stored at room (18-24 °C) and refrigerator temperature (4-8 °C) for 15 days. The stored urine samples were tested with both an in-house validated real-time PCR and MG-TMA assay after transfer of the original urine samples to the respective test tubes at 3, 7, 12 and 15 days post collection.
RESULTS
RESULTS
In total, 47 MG-positive urine samples were collected, stored and tested for MG by real-time PCR and TMA assays. After storage at room temperature, the MG-detection rate by TMA was significantly higher compared to real-time PCR, at days 0 (p ≤ 0.001), 7 (p ≤ 0.001) and 12 (p < 0.05). After storage at refrigerator temperature, the MG-detection rate determined by TMA assay was significantly enhanced in comparison with real-time PCR at days 3 (p < 0.01), 7 (p ≤ 0.001) and 15 (p < 0.01).
CONCLUSIONS
CONCLUSIONS
This validation study showed that the MG-TMA assay has a superior detection rate in urine compared to real-time PCR, up to 15 days post sample collection and irrespective of storage temperature. Accepting urines older than 24 h to be tested by TMA will improve clinical diagnosis of MG infections.
Identifiants
pubmed: 37667184
doi: 10.1186/s12879-023-08499-z
pii: 10.1186/s12879-023-08499-z
pmc: PMC10476297
doi:
Substances chimiques
methyl salicylate
LAV5U5022Y
Capsaicin
S07O44R1ZM
Menthol
1490-04-6
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
574Informations de copyright
© 2023. BioMed Central Ltd., part of Springer Nature.
Références
Gnanadurai R, Fifer H. Mycoplasma genitalium: a review. (1465–2080 (Electronic)).
Jensen JS, Cusini M, Gomberg M, Moi H, Wilson J, Unemo M. 2021 european guideline on the management of Mycoplasma genitalium infections. J Eur Acad Dermatol Venereol. 2022;36(5):641–50.
doi: 10.1111/jdv.17972
Tabrizi SN, Costa AM, Su J, Lowe P, Bradshaw CS, Fairley CK, et al. Evaluation of the hologic panther transcription-mediated amplification assay for detection of Mycoplasma genitalium. J Clin Microbiol. 2016;54(8):2201–3.
doi: 10.1128/JCM.01038-16
Jensen JS, Björnelius E, Dohn B, Lidbrink P. Use of TaqMan 5’ nuclease real-time PCR for quantitative detection of Mycoplasma genitalium DNA in males with and without urethritis who were attendees at a sexually transmitted disease clinic. J Clin Microbiol. 2004;42(2):683–92.
doi: 10.1128/JCM.42.2.683-692.2004
Wroblewski JK, Manhart LE, Dickey KA, Hudspeth MK, Totten PA. Comparison of transcription-mediated amplification and PCR assay results for various genital specimen types for detection of Mycoplasma genitalium. J Clin Microbiol. 2006;44(9):3306–12.
doi: 10.1128/JCM.00553-06
Chernesky M, Jang D, Gilchrist J, Hatchette T, Poirier A, Flandin JF et al. Head-to-head comparison of second-generation nucleic acid amplification tests for detection of Chlamydia trachomatis and Neisseria gonorrhoeae on urine samples from female subjects and self-collected vaginal swabs. (1098-660X (Electronic)).
de Salazar A, Espadafor B, Fuentes-López A, Barrientos-Durán A, Salvador L, Álvarez M et al. Comparison between Aptima assays (Hologic) and the Allplex STI essential assay (Seegene) for the diagnosis of sexually transmitted infections. (1932–6203 (Electronic)).
Salado-Rasmussen K, Tolstrup J, Sedeh FB, Larsen HK, Unemo M, Jensen JS. Clinical importance of Superior Sensitivity of the Aptima TMA-Based assays for Mycoplasma genitalium detection. J Clin Microbiol. 2022;60(4):e0236921.
doi: 10.1128/jcm.02369-21
Gorzalski AJ, Tian H, Laverdure C, Morzunov S, Verma SC, VanHooser S et al. High-throughput transcription-mediated amplification on the Hologic panther is a highly sensitive method of detection for SARS-CoV-2. (1873–5967 (Electronic)).
Braam JF, Hetem DJ, Vergunst CE, Kuizenga Wessel S, van Rooijen MS, Nijhuis RHT, et al. Evaluating the prevalence and risk factors for macrolide resistance in Mycoplasma genitalium using a newly developed qPCR assay. PLoS ONE. 2020;15(10):e0240836.
doi: 10.1371/journal.pone.0240836
Kirkconnell B, Weinbaum B, Santos K, Le Nguyen T, Vinluan B, Astete S et al. Design and validation of transcription-mediated-amplification nucleic acid amplification tests for Mycoplasma genitalium. LID – 10.1128/JCM.00264 – 19 LID - e00264-19. (1098-660X (Electronic)).
van der Veer C, van Rooijen MS, Himschoot M, de Vries HA-OX, Bruisten SM. Trichomonas vaginalis and Mycoplasma genitalium: age-specific prevalence and disease burden in men attending a sexually transmitted infections clinic in Amsterdam, the Netherlands. (1472–3263 (Electronic)).
Hetem DA-O, Kuizenga Wessel S, Bruisten SM, Braam JF, van Rooijen MS, Vergunst CE et al. High prevalence and resistance rates of Mycoplasma genitalium among patients visiting two sexually transmitted infection clinics in the Netherlands. (1758 – 1052 (Electronic)).
Unemo M, Salado-Rasmussen K, Hansen M, Olsen AO, Falk M, Golparian D, et al. Clinical and analytical evaluation of the new Aptima Mycoplasma genitalium assay, with data on M. genitalium prevalence and antimicrobial resistance in M. genitalium in Denmark, Norway and Sweden in 2016. Clin Microbiol Infect. 2018;24(5):533–9.
doi: 10.1016/j.cmi.2017.09.006